Bayer loses out as India issues its first compulsory licence

The Indian Patent Office has today decreed that Bayer must license the right to produce its patented anti-cancer treatment Nexavar to generic company Natco. This is the first compulsory licence issued in India since the country signed up to TRIPs…

Get unlimited access to all IAM content